NLRP3 and type 2 diabetes mellitus: Enhanced expression of NLRP3 in monocytes has been observed in patients with T2D [117], while T2D rats have exhibited heightened activation of NLRP3, resulting in intensified cardiac inflammation, cell death, disrupted ultrastructure, and fibrosis [118].